BioSense Global Exercised its Option with Neovacs
| Press Release
BioSense Global has exercised its option to acquire the exclusive licence for Neovacs‘ IFNα Kinoid to treat lupus in China. Learn more
BioSense News
| Press Release
BioSense Global has exercised its option to acquire the exclusive licence for Neovacs‘ IFNα Kinoid to treat lupus in China. Learn more